Novo Nordisk 's ( NVO +2.93%) shareholders must be happy to see 2025 finally come to a close. It was not a good year for the ...

Novo Nordisk announces China’s Supreme People’s Court delivers positive ruling on semaglutide compound patent: Bagsværd, Denmark Saturday, January 3, 2026, 17:00 Hrs [IST] Th ...

In Nation Healthcare Security Administration’s (NHSA’s) announcement for the 2025 NRDL, the government’s support for ...

Today, the Supreme People’s Court in China made a positive decision concerning the intellectual property rights relating to ...

Today, the Supreme People’s Court in China made a positive decision concerning the intellectual property rights relating to ...

Global stocks have seen a stellar run this year, even as sharp divergences opened up between the world's best and worst ...

Novo Nordisk’s oral Wegovy gets FDA approval, but rising costs and competition threaten profits. Learn why analysts rate NVO ...

Novo did not give details on the new prices, but media outlet Yicai reported ‍earlier that list prices for ​the two highest ...

Explore the transformation of weight-loss drugs with the rise of GLP-1 pills, the impact of telehealth, and consumer-driven healthcare approaches, and how these trends are changing the landscape of ...

Study finds processed foods may trick bodies into thinking it's summer. Scientists found a hidden seasonal timer that reads ...

Joel F. Habener, a Harvard University academic whose research paved the way for revolutionary weight-loss drugs Ozempic, ...

Novo Nordisk should remain one of the leaders in the fast-growing weight loss market, and the company's shares are trading at ...